Literature DB >> 8463547

Acromegalic cardiopathy: a left ventricular scintigraphic study.

N Sicolo1, F Bui, M Sicolo, L Varotto, C Martini, C Macor, G Federspil.   

Abstract

In order to study "acromegalic cardiomyopathy", cardiac function was examined, using gated radionuclide ventriculography, in 18 acromegalic patients and 21 control subjects with no clinical evidence of cardiac involvement. In these acromegalic subjects, while the Ejection Fraction (EF) did not appear to be significantly different, the Peak Filling Rate (PFR) was reduced while the Time to Peak Filling Rate (TPFR) resulted significantly greater than in control subjects. These findings indicate that chronic growth hormone (GH) hypersecretion, as observed in acromegaly, deteriorate the cardiac ventricular relaxation (diastolic phase) while it has no influence on contractility (systolic phase).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463547     DOI: 10.1007/BF03347663

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Acromegaly.

Authors:  G J HAMWI; T G SKILLMAN; K C TUFTS
Journal:  Am J Med       Date:  1960-10       Impact factor: 4.965

2.  Dysrhythmias and sudden death in acromegalic heart disease. A clinicopathologic study.

Authors:  L Rossi; G Thiene; L Caragaro; R Giordano; S Lauro
Journal:  Chest       Date:  1977-10       Impact factor: 9.410

3.  Optimum fourier filtering of cardiac data: a minimum-error method: concise communication.

Authors:  S L Bacharach; M V Green; D Vitale; G White; M A Douglas; R O Bonow; S M Larson
Journal:  J Nucl Med       Date:  1983-12       Impact factor: 10.057

4.  A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.

Authors:  R J Callahan; J W Froelich; K A McKusick; J Leppo; H W Strauss
Journal:  J Nucl Med       Date:  1982-04       Impact factor: 10.057

5.  Evidence of subclinical heart muscle dysfunction in acromegaly.

Authors:  E A Jonas; J F Aloia; F J Lane
Journal:  Chest       Date:  1975-02       Impact factor: 9.410

6.  The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study.

Authors:  L Thuesen; S E Christensen; J Weeke; H Orskov; P Henningsen
Journal:  Clin Endocrinol (Oxf)       Date:  1989-06       Impact factor: 3.478

7.  [The acromegalic heart disease (author's transl)].

Authors:  G Thiene; R Giordano; M Valente; N Pennelli; L Rossi
Journal:  G Ital Cardiol       Date:  1980

8.  Heart size and function in acromegaly.

Authors:  H M Mather; M J Boyd; J S Jenkins
Journal:  Br Heart J       Date:  1979-06

9.  Cardiac size and function in acromegaly.

Authors:  J B Martins; R E Kerber; B M Sherman; M L Marcus; J C Ehrhardt
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

10.  Echocardiographic assessment of cardiac anatomy and function in acromegalic patients.

Authors:  D D Savage; W L Henry; R C Eastman; J S Borer; P Gorden
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

View more
  5 in total

1.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  Quantifying subtle changes in cardiovascular mechanics in acromegaly: a Doppler myocardial imaging study.

Authors:  R Jurcut; S Găloiu; A Florian; A Vlădaia; O R Ioniţă; M S Amzulescu; I Baciu; B A Popescu; M Coculescu; C Ginghina
Journal:  J Endocrinol Invest       Date:  2014-08-15       Impact factor: 4.256

3.  Acromegalic cardiomyopathy: evaluation of the left ventricular diastolic function in the subclinical stage.

Authors:  N Ozbey; A Oncül; Z Buğra; A Vural; F Erzengin; Y Orhan; K Büyüköztürk; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 4.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

5.  Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study.

Authors:  G Lombardi; A Colao; P Marzullo; B Biondi; E Palmieri; S Fazio
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.